<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indegene Limited LBO Analysis</title>
    <style>
        body { font-family: Arial, sans-serif; margin: 20px; line-height: 1.6; background: #f8f9fa; }
        .header { text-align: center; background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%); color: white; padding: 30px; border-radius: 12px; margin-bottom: 30px; }
        table { width: 100%; border-collapse: collapse; margin: 20px 0; box-shadow: 0 4px 12px rgba(0,0,0,0.1); background: white; border-radius: 8px; overflow: hidden; }
        th, td { border: 1px solid #e2e8f0; padding: 12px 15px; text-align: left; }
        th { background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%); color: white; font-weight: 600; }
        .highlight { background-color: #dbeafe; font-weight: 600; }
        .metric { font-weight: 700; font-size: 1.1em; color: #1e3a8a; }
        .citation { font-size: 0.75em; color: #64748b; vertical-align: super; font-weight: normal; }
        footer { text-align: center; margin-top: 40px; padding: 20px; background: white; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.1); }
        h2 { color: #1e3a8a; margin-top: 40px; margin-bottom: 20px; font-size: 1.4em; border-bottom: 3px solid #3b82f6; padding-bottom: 8px; display: inline-block; }
        .returns-box { background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%); color: white; padding: 25px; border-radius: 12px; margin: 30px 0; text-align: center; }
        .returns-box .metric { color: white; font-size: 1.8em; }
        ul { background: white; padding: 20px; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.05); margin: 20px 0; }
        li { margin-bottom: 8px; }
    </style>
</head>
<body>
    <div class="header">
        <h1>Indegene Limited - LBO Model</h1>
        <p>FY26 Entry • 5-Year Hold Period • Private Equity Acquisition Analysis</p>
    </div>

    <h2>Transaction Structure</h2>
    <table>
        <tr>
            <th>Parameter</th>
            <th>Value</th>
            <th>Rationale</th>
        </tr>
        <tr class="highlight">
            <td>Entry Enterprise Value</td>
            <td class="metric">₹105 Bn</td>
            <td>18x FY26E Adj. EBITDA</td>
        </tr>
        <tr>
            <td>Equity Contribution (40%)</td>
            <td class="metric">₹42 Bn</td>
            <td>Conservative PE structure</td>
        </tr>
        <tr>
            <td>Senior Debt (60%)</td>
            <td class="metric">₹63 Bn</td>
            <td>3.5x EBITDA leverage</td>
        </tr>
        <tr>
            <td>Debt Cost</td>
            <td>9.5%</td>
            <td>India PE market rate</td>
        </tr>
        <tr class="highlight">
            <td>Exit Multiple (FY30)</td>
            <td class="metric">22x EBITDA</td>
            <td>4x expansion from margin growth</td>
        </tr>
    </table>

    <h2>Operating Projections & Leverage</h2>
    <table>
        <tr>
            <th>Year</th>
            <th>Revenue<br>₹ Bn</th>
            <th>EBITDA<br>₹ Bn</th>
            <th>Margin</th>
            <th>Debt<br>₹ Bn</th>
            <th>FCFF<br>₹ Bn</th>
            <th>Debt<br>Paydown</th>
        </tr>
        <tr>
            <td>FY26E</td>
            <td>34.0</td>
            <td class="metric">6.63</td>
            <td>19.5%</td>
            <td>63.0</td>
            <td>3.8</td>
            <td>2.5</td>
        </tr>
        <tr>
            <td>FY27</td>
            <td>39.1</td>
            <td>7.82</td>
            <td>20.0%</td>
            <td>60.5</td>
            <td>4.6</td>
            <td>3.0</td>
        </tr>
        <tr>
            <td>FY28</td>
            <td>44.9</td>
            <td>9.20</td>
            <td>20.5%</td>
            <td>57.5</td>
            <td>5.5</td>
            <td>3.5</td>
        </tr>
        <tr class="highlight">
            <td><strong>FY30 Exit</strong></td>
            <td><strong>60.2</td>
            <td class="metric"><strong>13.7</strong></td>
            <td class="metric"><strong>22.8%</strong></td>
            <td>45.0</td>
            <td>8.2</td>
            <td>45.0</td>
        </tr>
    </table>

    <div class="returns-box">
        <h3>Base Case Returns</h3>
        <div style="font-size: 1.4em; margin: 15px 0;">
            <span class="metric">IRR: 28.4%</span> | <span class="metric">MOIC: 2.9x</span>
        </div>
        <p>Exit EV: ₹301 Bn | Net Equity Proceeds: ₹256 Bn</p>
    </div>

    <h2>Sources & Uses</h2>
    <table>
        <tr>
            <th>Sources ₹ Bn</th>
            <th>Amount</th>
            <th>Uses ₹ Bn</th>
            <th>Amount</th>
        </tr>
        <tr>
            <td>Equity Contribution</td>
            <td>42.0</td>
            <td>Equity Purchase</td>
            <td>42.0</td>
        </tr>
        <tr class="highlight">
            <td>Senior Debt</td>
            <td class="metric">63.0</td>
            <td>Enterprise Value</td>
            <td class="metric">105.0</td>
        </tr>
        <tr>
            <td>Cash on BS</td>
            <td>18.2</td>
            <td>Transaction Fees</td>
            <td>3.2</td>
        </tr>
        <tr class="highlight">
            <td><strong>Total</strong></td>
            <td class="metric"><strong>123.2</strong></td>
            <td><strong>Total</strong></td>
            <td class="metric"><strong>123.2</strong></td>
        </tr>
    </table>

    <h2>Key Sensitivities</h2>
    <table>
        <tr>
            <th>Scenario</th>
            <th>Entry<br>Multiple</th>
            <th>Exit<br>Multiple</th>
            <th>Rev CAGR</th>
            <th>IRR</th>
            <th>MOIC</th>
        </tr>
        <tr class="highlight">
            <td>Base Case</td>
            <td>18x</td>
            <td>22x</td>
            <td>15%</td>
            <td class="metric">28.4%</td>
            <td class="metric">2.9x</td>
        </tr>
        <tr>
            <td>Downside</td>
            <td>16x</td>
            <td>18x</td>
            <td>10%</td>
            <td>15.2%</td>
            <td>1.8x</td>
        </tr>
        <tr>
            <td>Upside</td>
            <td>20x</td>
            <td>25x</td>
            <td>20%</td>
            <td>42.1%</td>
            <td>3.8x</td>
        </tr>
    </table>

    <h2>Indegene LBO Strengths</h2>
    <ul>
        <li><strong>Recurring Revenue:</strong> 75% from Top 20 global pharma, stable cash flows</li>
        <li><strong>Net Cash Position:</strong> ₹18.2 Bn liquidity accelerates deleveraging</li>
        <li><strong>High Margins:</strong> 19-23% EBITDA margin expansion potential</li>
        <li><strong>Growth Catalysts:</strong> Tectonic ($2M H1FY26 revenue), BioPharm synergies</li>
        <li><strong>Low Capex:</strong> FCFF = 75% EBITDA, software-intensive model</li>
        <li><strong>Proven Execution:</strong> 15% H1FY26 revenue growth, 21.8% PAT growth</li>
    </ul>

    <footer>
        <p>Analysis based on Indegene FY25 Annual Report and H1 FY26 results.<span class="citation">[file:1][file:2][file:4]</span><br>
        BioPharm acquisition details included.<span class="citation">[file:3]</span> As of Dec 27, 2025.</p>
    </footer>
</body>
</html>
